Nonalcoholic fatty liver disease is an increasingly recognizedcondition that may progress to end-stage liver disease. Thepathological picture resembles that of alcohol-induced liverinjury, but it occurs in patients who do not abuse alcohol.1,2A variety of terms have been used to describe this entity, includingfatty-liver hepatitis, nonalcoholic Laënnec's disease,diabetes hepatitis, alcohol-like liver disease, and nonalcoholicsteatohepatitis. Nonalcoholic fatty liver disease is becomingthe preferred term, and it refers to a wide spectrum of liverdamage, ranging from simple steatosis to steatohepatitis, advancedfibrosis, and cirrhosis. Steatohepatitis (nonalcoholic steatohepatitis)represents only a stage within the spectrum of . . . [Full Text of this Article]
Epidemiologic Features
Risk Factors
Prevalence
Clinical Manifestations
Clinical Features
Laboratory Abnormalities
Imaging Studies
Histologic Findings
Pathogenesis
Diagnosis
Role of Liver Biopsy
Natural History
Management
Associated Conditions
Drug Therapy
General Recommendations
Conclusions
Source Information
From the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minn.
Address reprint requests to Dr. Angulo at the Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First St. SW, Rochester, MN 55905, or at angulohernandez.paul@mayo.edu.
References
Related Letters:
Nonalcoholic Fatty Liver Disease
Bode J. C., Inzucchi S. E., Petersen K. F., Shulman G. I., Babb R. R., Marignani M., Angeletti S., Angulo P.
Extract |
Full Text |
PDF
N Engl J Med 2002;
347:768-769, Sep 5, 2002.
Correspondence
This article has been cited by other articles:
Vassilatou, E., Lafoyianni, S., Vryonidou, A., Ioannidis, D., Kosma, L., Katsoulis, K., Papavassiliou, E., Tzavara, I.
(2009). Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod
0: dep380v1-dep380
[Abstract][Full Text]
Nobili, V., Day, C.
(2009). Childhood NAFLD: a ticking time-bomb?. Gut
58: 1442-1442
[Full Text]
Feldstein, A E, Charatcharoenwitthaya, P, Treeprasertsuk, S, Benson, J T, Enders, F B, Angulo, P
(2009). The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut
58: 1538-1544
[Abstract][Full Text]
Kantartzis, K., Peter, A., Machicao, F., Machann, J., Wagner, S., Konigsrainer, I., Konigsrainer, A., Schick, F., Fritsche, A., Haring, H.-U., Stefan, N.
(2009). Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene. Diabetes
58: 2616-2623
[Abstract][Full Text]
Yamazaki, Y., Usui, I., Kanatani, Y., Matsuya, Y., Tsuneyama, K., Fujisaka, S., Bukhari, A., Suzuki, H., Senda, S., Imanishi, S., Hirata, K., Ishiki, M., Hayashi, R., Urakaze, M., Nemoto, H., Kobayashi, M., Tobe, K.
(2009). Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. Am. J. Physiol. Endocrinol. Metab.
297: E1179-E1186
[Abstract][Full Text]
Masuoka, H. C., Mott, J., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kaufmann, S. H., Gores, G. J.
(2009). Mcl-1 Degradation during Hepatocyte Lipoapoptosis. J. Biol. Chem.
284: 30039-30048
[Abstract][Full Text]
Petit, J. M., Guiu, B., Terriat, B., Loffroy, R., Robin, I., Petit, V., Bouillet, B., Brindisi, M.-C., Duvillard, L., Hillon, P., Cercueil, J.-P., Verges, B.
(2009). Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients. J. Clin. Endocrinol. Metab.
94: 4103-4106
[Abstract][Full Text]
Cussons, A. J., Watts, G. F., Mori, T. A., Stuckey, B. G. A.
(2009). Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy. J. Clin. Endocrinol. Metab.
94: 3842-3848
[Abstract][Full Text]
Denzer, C., Thiere, D., Muche, R., Koenig, W., Mayer, H., Kratzer, W., Wabitsch, M.
(2009). Gender-Specific Prevalences of Fatty Liver in Obese Children and Adolescents: Roles of Body Fat Distribution, Sex Steroids, and Insulin Resistance. J. Clin. Endocrinol. Metab.
94: 3872-3881
[Abstract][Full Text]
German, J., Kim, F., Schwartz, G. J., Havel, P. J., Rhodes, C. J., Schwartz, M. W., Morton, G. J.
(2009). Hypothalamic Leptin Signaling Regulates Hepatic Insulin Sensitivity via a Neurocircuit Involving the Vagus Nerve. Endocrinology
150: 4502-4511
[Abstract][Full Text]
Chang, Y, Ryu, S, Sung, E, Woo, H-Y, Cho, S-I, Yoo, S-H, Ahn, H-Y, Choi, N-K
(2009). Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut
58: 1419-1425
[Abstract][Full Text]
Qayyum, A.
(2009). MR Spectroscopy of the Liver: Principles and Clinical Applications. RadioGraphics
29: 1653-1664
[Abstract][Full Text]
Kantartzis, K, Thamer, C, Peter, A, Machann, J, Schick, F, Schraml, C, Konigsrainer, A, Konigsrainer, I, Krober, S, Niess, A, Fritsche, A, Haring, H-U, Stefan, N
(2009). High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut
58: 1281-1288
[Abstract][Full Text]
Wilbur, K.
(2009). Nonviral Hepatitis. Journal of Pharmacy Practice
22: 388-404
[Abstract]
Grefhorst, A., Parks, E. J.
(2009). Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice. J. Lipid Res.
50: 1374-1383
[Abstract][Full Text]
Taouli, B., Ehman, R. L., Reeder, S. B.
(2009). Advanced MRI Methods for Assessment of Chronic Liver Disease. Am. J. Roentgenol.
193: 14-27
[Abstract][Full Text]
Casillas-Ramirez, A., Zaouali, A., Padrissa-Altes, S., Ben Mosbah, I., Pertosa, A., Alfany-Fernandez, I., Bintanel-Morcillo, M., Xaus, C., Rimola, A., Rodes, J., Rosello-Catafau, J., Peralta, C.
(2009). Insulin-Like Growth Factor and Epidermal Growth Factor Treatment: New Approaches to Protecting Steatotic Livers against Ischemia-Reperfusion Injury. Endocrinology
150: 3153-3161
[Abstract][Full Text]
Bhala, N., Bhopal, R., Brock, A., Griffiths, C., Wild, S.
(2009). Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data. J Public Health (Oxf)
31: 250-257
[Abstract][Full Text]
Gonzalez-Periz, A., Horrillo, R., Ferre, N., Gronert, K., Dong, B., Moran-Salvador, E., Titos, E., Martinez-Clemente, M., Lopez-Parra, M., Arroyo, V., Claria, J.
(2009). Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins. FASEB J.
23: 1946-1957
[Abstract][Full Text]
Shields, W. W., Thompson, K.E., Grice, G.A., Harrison, S.A., Coyle, W.J.
(2009). The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial. Therapeutic Advances in Gastroenterology
2: 157-163
[Abstract]
Soder, R. B., Baldisserotto, M., da Silva, V. D.
(2009). Computer-Assisted Ultrasound Analysis of Liver Echogenicity in Obese and Normal-Weight Children. Am. J. Roentgenol.
192: W201-W205
[Abstract][Full Text]
Yoon, Y.-S., Seo, W.-Y., Lee, M.-W., Kim, S.-T., Koo, S.-H.
(2009). Salt-inducible Kinase Regulates Hepatic Lipogenesis by Controlling SREBP-1c Phosphorylation. J. Biol. Chem.
284: 10446-10452
[Abstract][Full Text]
Wei, Y., Clark, S. E., Thyfault, J. P., Uptergrove, G. M.E., Li, W., Whaley-Connell, A. T., Ferrario, C. M., Sowers, J. R., Ibdah, J. A.
(2009). Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats. Am. J. Pathol.
174: 1329-1337
[Abstract][Full Text]
Li, Z. Z., Berk, M., McIntyre, T. M., Feldstein, A. E.
(2009). Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease: ROLE OF STEAROYL-CoA DESATURASE. J. Biol. Chem.
284: 5637-5644
[Abstract][Full Text]
Palomba, S., Falbo, A., Zullo, F., Orio, F. Jr.
(2009). Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. Endocr. Rev.
30: 1-50
[Abstract][Full Text]
Ayala, I., Castillo, A. M., Adanez, G., Fernandez-Rufete, A., Perez, B. G., Castells, M. T.
(2009). Hyperlipidemic Chicken as a Model of Non-Alcoholic Steatohepatitis. Exp. Biol. Med.
234: 10-16
[Abstract][Full Text]
Guiu, B., Petit, J.-M., Loffroy, R., Ben Salem, D., Aho, S., Masson, D., Hillon, P., Krause, D., Cercueil, J.-P.
(2009). Quantification of Liver Fat Content: Comparison of Triple-Echo Chemical Shift Gradient-Echo Imaging and in Vivo Proton MR Spectroscopy. Radiology
250: 95-102
[Abstract][Full Text]
Borra, R. J. H., Salo, S., Dean, K., Lautamaki, R., Nuutila, P., Komu, M., Parkkola, R.
(2009). Nonalcoholic Fatty Liver Disease: Rapid Evaluation of Liver Fat Content with In-Phase and Out-of-Phase MR Imaging. Radiology
250: 130-136
[Abstract][Full Text]
Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H.-G., Haring, H.-U., Boeing, H., Fritsche, A.
(2008). Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke. Circulation
118: 2555-2562
[Abstract][Full Text]
Stefan, N., Kantartzis, K., Haring, H.-U.
(2008). Causes and Metabolic Consequences of Fatty Liver. Endocr. Rev.
29: 939-960
[Abstract][Full Text]
Manco, M., Bottazzo, G., DeVito, R., Marcellini, M., Mingrone, G., Nobili, V.
(2008). Nonalcoholic Fatty Liver Disease in Children. J. Am. Coll. Nutr.
27: 667-676
[Abstract][Full Text]
Lopez-Parra, M., Titos, E., Horrillo, R., Ferre, N., Gonzalez-Periz, A., Martinez-Clemente, M., Planaguma, A., Masferrer, J., Arroyo, V., Claria, J.
(2008). Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice. J. Lipid Res.
49: 2513-2523
[Abstract][Full Text]
Furlan, A., van der Windt, D. J., Nalesnik, M. A., Sholosh, B., Ngan, K.-K., Pealer, K. M., Ijzermans, J. N. M., Federle, M. P.
(2008). Multiple Hepatic Adenomas Associated with Liver Steatosis at CT and MRI: A Case-Control Study. Am. J. Roentgenol.
191: 1430-1435
[Abstract][Full Text]
Fujita, K, Nozaki, Y, Wada, K, Yoneda, M, Endo, H, Takahashi, H, Iwasaki, T, Inamori, M, Abe, Y, Kobayashi, N, Kirikoshi, H, Kubota, K, Saito, S, Nagashima, Y, Nakajima, A
(2008). Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut
57: 1583-1591
[Abstract][Full Text]
KIM, C. H., YOUNOSSI, Z. M.
(2008). Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome. Cleveland Clinic Journal of Medicine
75: 721-728
[Abstract][Full Text]
Stefan, N., Fritsche, A., Weikert, C., Boeing, H., Joost, H.-G., Haring, H.-U., Schulze, M. B.
(2008). Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes. Diabetes
57: 2762-2767
[Abstract][Full Text]
Li, T., Ma, H., Chiang, J. Y. L.
(2008). TGF{beta}1, TNF{alpha}, and insulin signaling crosstalk in regulation of the rat cholesterol 7{alpha}-hydroxylase gene expression. J. Lipid Res.
49: 1981-1989
[Abstract][Full Text]
Varela, G. M., Antwi, D. A., Dhir, R., Yin, X., Singhal, N. S., Graham, M. J., Crooke, R. M., Ahima, R. S.
(2008). Inhibition of ADRP prevents diet-induced insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol.
295: G621-G628
[Abstract][Full Text]
Boden, G., Song, W., Kresge, K., Mozzoli, M., Cheung, P.
(2008). Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors. Am. J. Physiol. Endocrinol. Metab.
295: E692-E697
[Abstract][Full Text]
Singhal, N. S., Patel, R. T., Qi, Y., Lee, Y.-S., Ahima, R. S.
(2008). Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am. J. Physiol. Endocrinol. Metab.
295: E331-E338
[Abstract][Full Text]
Lindsay, K., Gough, A.
(2008). Psoriatic arthritis, methotrexate and the liver--are rheumatologists putting their patients at risk?. Rheumatology (Oxford)
47: 939-941
[Full Text]
Marra, F.
(2008). Nuclear factor-{kappa}B inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy. Gut
57: 570-572
[Full Text]
Beraza, N, Malato, Y, Vander Borght, S, Liedtke, C, Wasmuth, H E, Dreano, M, de Vos, R, Roskams, T, Trautwein, C
(2008). Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut
57: 655-663
[Abstract][Full Text]
Ramaiah, S. K., Rittling, S.
(2008). Pathophysiological Role of Osteopontin in Hepatic Inflammation, Toxicity, and Cancer. Toxicol Sci
103: 4-13
[Abstract][Full Text]
Kechagias, S, Ernersson, A, Dahlqvist, O, Lundberg, P, Lindstrom, T, Nystrom, F H, for the Fast Food Study Group,
(2008). Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut
57: 649-654
[Abstract][Full Text]
Stefanovic-Racic, M., Perdomo, G., Mantell, B. S., Sipula, I. J., Brown, N. F., O'Doherty, R. M.
(2008). A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab.
294: E969-E977
[Abstract][Full Text]
Stefan, N., Kantartzis, K., Haring, H.-U.
(2008). Cardiorespiratory Fitness, Adiposity, and Mortality. JAMA
299: 1013-1014
[Full Text]
Browning, L. M, Krebs, J. D, Siervo, M., Hall, R. M, Finer, N., Allison, M. E., Jebb, S. A
(2008). Inflammation is associated with liver function markers, independent of other metabolic risk factors in overweight women. British Journal of Diabetes & Vascular Disease
8: 73-76
[Abstract]
Gao, F., Linhartova, L., Johnston, A. McD., Thickett, D. R.
(2008). Statins and sepsis. Br J Anaesth
100: 288-298
[Abstract][Full Text]
Bruno, R. S., Dugan, C. E., Smyth, J. A., DiNatale, D. A., Koo, S. I.
(2008). Green Tea Extract Protects Leptin-Deficient, Spontaneously Obese Mice from Hepatic Steatosis and Injury. J. Nutr.
138: 323-331
[Abstract][Full Text]
Weiss, R., Kaufman, F. R.
(2008). Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk. Diabetes Care
31: S310-S316
[Abstract][Full Text]
Kotronen, A., Juurinen, L., Hakkarainen, A., Westerbacka, J., Corner, A., Bergholm, R., Yki-Jarvinen, H.
(2008). Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic Subjects. Diabetes Care
31: 165-169
[Abstract][Full Text]
De Ferranti, S. D, Osganian, S. K
(2007). Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diabetes and Vascular Disease Research
4: 285-296
[Abstract]
Strauss, S., Gavish, E., Gottlieb, P., Katsnelson, L.
(2007). Interobserver and Intraobserver Variability in the Sonographic Assessment of Fatty Liver. Am. J. Roentgenol.
189: W320-W323
[Abstract][Full Text]
Cali, A. M.G., Zern, T. L., Taksali, S. E., de Oliveira, A. M., Dufour, S., Otvos, J. D., Caprio, S.
(2007). Intrahepatic Fat Accumulation and Alterations in Lipoprotein Composition in Obese Adolescents: A perfect proatherogenic state. Diabetes Care
30: 3093-3098
[Abstract][Full Text]
Lin, C.-L., Huang, H.-C., Lin, J.-K.
(2007). Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J. Lipid Res.
48: 2334-2343
[Abstract][Full Text]
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., Otsuki, M.
(2007). Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men. Diabetes Care
30: 2940-2944
[Abstract][Full Text]
Huang, X., Yang, C., Luo, Y., Jin, C., Wang, F., McKeehan, W. L.
(2007). FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet Induced Fatty Liver. Diabetes
56: 2501-2510
[Abstract][Full Text]
Barbuio, R., Milanski, M., Bertolo, M. B, Saad, M. J, Velloso, L. A
(2007). Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol
194: 539-550
[Abstract][Full Text]
Kumazawa, M., Kobayashi, M., Io, F., Kawai, T., Nishimura, M., Ohno, T., Horio, F.
(2007). Searching for genetic factors of fatty liver in SMXA-5 mice by quantitative trait loci analysis under a high-fat diet. J. Lipid Res.
48: 2039-2046
[Abstract][Full Text]
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., Arcaro, G.
(2007). Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients. Diabetes Care
30: 2119-2121
[Full Text]
Rice, L., Hursting, M. J., Baillie, G. M., McCollum, D. A.
(2007). Argatroban Anticoagulation in Obese Versus Nonobese Patients: Implications for Treating Heparin-induced Thrombocytopenia. J Clin Pharmacol
47: 1028-1034
[Full Text]
Kohli, R., Pan, X., Malladi, P., Wainwright, M. S., Whitington, P. F.
(2007). Mitochondrial Reactive Oxygen Species Signal Hepatocyte Steatosis by Regulating the Phosphatidylinositol 3-Kinase Cell Survival Pathway. J. Biol. Chem.
282: 21327-21336
[Abstract][Full Text]
Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., Chou, P.
(2007). Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study. Am J Epidemiol
166: 196-203
[Abstract][Full Text]
Pagliassotti, M. J., Wei, Y., Wang, D.
(2007). Insulin Protects Liver Cells from Saturated Fatty Acid-Induced Apoptosis via Inhibition of c-Jun NH2 Terminal Kinase Activity. Endocrinology
148: 3338-3345
[Abstract][Full Text]
Kosone, T., Takagi, H., Horiguchi, N., Ariyama, Y., Otsuka, T., Sohara, N., Kakizaki, S., Sato, K., Mori, M.
(2007). HGF ameliorates a high-fat diet-induced fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol.
293: G204-G210
[Abstract][Full Text]
Azuma, K., Heilbronn, L. K., Albu, J. B., Smith, S. R., Ravussin, E., Kelley, D. E., and the Look AHEAD Adipose Research Group,
(2007). Adipose tissue distribution in relation to insulin resistance in type 2 diabetes mellitus. Am. J. Physiol. Endocrinol. Metab.
293: E435-E442
[Abstract][Full Text]
Jakobsen, M., Berentzen, T, Sorensen, T., Overvad, K
(2007). Abdominal Obesity and Fatty Liver. Epidemiol Rev
0: mxm002v1-
[Abstract][Full Text]
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., Arcaro, G.
(2007). Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients. Diabetes Care
30: 1212-1218
[Abstract][Full Text]
Ryan, M. C., Abbasi, F., Lamendola, C., Carter, S., McLaughlin, T. L.
(2007). Serum Alanine Aminotransferase Levels Decrease Further With Carbohydrate Than Fat Restriction in Insulin-Resistant Adults. Diabetes Care
30: 1075-1080
[Abstract][Full Text]
Hasegawa, T., Ito, Y., Wijeweera, J., Liu, J., Malle, E., Farhood, A., McCuskey, R. S., Jaeschke, H.
(2007). Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G1385-G1395
[Abstract][Full Text]
Iannaccone, R., Piacentini, F., Murakami, T., Paradis, V., Belghiti, J., Hori, M., Kim, T., Durand, F., Wakasa, K., Monden, M., Nakamura, H., Passariello, R., Vilgrain, V.
(2007). Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Helical CT and MR Imaging Findings with Clinical-Pathologic Comparison. Radiology
243: 422-430
[Abstract][Full Text]
Daugherty, K. K., Subramanian, J.
(2007). Pravastatin-Induced Hepatotoxicity in a Patient With Fatty Liver Disease: A Case Presentation With Literature Review. Journal of Pharmacy Practice
20: 192-197
[Abstract]
Chang, Y., Ryu, S., Sung, E., Jang, Y.
(2007). Higher Concentrations of Alanine Aminotransferase within the Reference Interval Predict Nonalcoholic Fatty Liver Disease. Clin. Chem.
53: 686-692
[Abstract][Full Text]
Targher, G., Chavez-Tapia, N. C., Barrientos-Gutierrez, T., Uribe, M., Ota, T., Takamura, T., Kaneko, S., Harrison, S. A., Schenker, S., Cusi, K.
(2007). Pioglitazone in Nonalcoholic Steatohepatitis. NEJM
356: 1067-1069
[Full Text]
Assy, N., Hussein, O., Abassi, Z.
(2007). Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis. Gut
56: 443-444
[Full Text]
Tolman, K. G., Fonseca, V., Dalpiaz, A., Tan, M. H.
(2007). Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Diabetes Care
30: 734-743
[Full Text]
Wang, Z., Xia, B., Ma, C., Hu, Z., Chen, X., Cao, P.
(2007). Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad. Med. J.
83: 192-195
[Abstract][Full Text]
Saadeh, S.
(2007). Nonalcoholic Fatty Liver Disease and Obesity. Nutr Clin Pract
22: 1-10
[Abstract][Full Text]
Grundy, S. M.
(2007). Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk. Arterioscler. Thromb. Vasc. Bio.
27: 4-7
[Full Text]
Fishman, S., Muzumdar, R. H., Atzmon, G., Ma, X., Yang, X., Einstein, F. H., Barzilai, N.
(2007). Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J.
21: 53-60
[Abstract][Full Text]
Bertolani, C., Sancho-Bru, P., Failli, P., Bataller, R., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Gines, P., Colmenero, J., Parola, M., Gelmini, S., Tarquini, R., Laffi, G., Pinzani, M., Marra, F.
(2006). Resistin as an Intrahepatic Cytokine: Overexpression during Chronic Injury and Induction of Proinflammatory Actions in Hepatic Stellate Cells. Am. J. Pathol.
169: 2042-2053
[Abstract][Full Text]
Alwayn, I. P. J., Andersson, C., Lee, S., Arsenault, D. A., Bistrian, B. R., Gura, K. M., Nose, V., Zauscher, B., Moses, M., Puder, M.
(2006). Inhibition of matrix metalloproteinases increases PPAR-{alpha} and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am. J. Physiol. Gastrointest. Liver Physiol.
291: G1011-G1019
[Abstract][Full Text]
Nobili, V., Manco, M., Ciampalini, P., Diciommo, V., Devito, R., Piemonte, F., Comparcola, D., Guidi, R., Marcellini, M.
(2006). Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.. Eur J Endocrinol
155: 735-743
[Abstract][Full Text]
Baumann, U., Brown, R.
(2006). Review: Non-alcoholic fatty liver disease in childhood. British Journal of Diabetes & Vascular Disease
6: 264-268
[Abstract]
Burgert, T. S., Taksali, S. E., Dziura, J., Goodman, T. R., Yeckel, C. W., Papademetris, X., Constable, R. T., Weiss, R., Tamborlane, W. V., Savoye, M., Seyal, A. A., Caprio, S.
(2006). Alanine Aminotransferase Levels and Fatty Liver in Childhood Obesity: Associations with Insulin Resistance, Adiponectin, and Visceral Fat. J. Clin. Endocrinol. Metab.
91: 4287-4294
[Abstract][Full Text]
Hamer, O. W., Aguirre, D. A., Casola, G., Lavine, J. E., Woenckhaus, M., Sirlin, C. B.
(2006). Fatty Liver: Imaging Patterns and Pitfalls. RadioGraphics
26: 1637-1653
[Abstract][Full Text]
Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J. R.B., Girard, J., Postic, C.
(2006). Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice.. Diabetes
55: 2159-2170
[Abstract][Full Text]
Lautamaki, R., Borra, R., Iozzo, P., Komu, M., Lehtimaki, T., Salmi, M., Jalkanen, S., Airaksinen, K. E. J., Knuuti, J., Parkkola, R., Nuutila, P.
(2006). Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab.
291: E282-E290
[Abstract][Full Text]
Wei, Y., Wang, D., Topczewski, F., Pagliassotti, M. J.
(2006). Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab.
291: E275-E281
[Abstract][Full Text]
Carpentier, Y. A, Portois, L., Malaisse, W. J
(2006). n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr.
83: S1499-1504S
[Abstract][Full Text]
Previous
